ExperimentHiC in situ Hi-C on H9 with targeted integration of GFP-tagged MYL2 differentiated to cardiac muscle cell with MboI

in situ Hi-C4DNEXNDUF85T
released
View JSON

Replicate 2 in situ Hi-C on H9 hESC cells, containing a MYL2-H2B-GFP marker for cardiocytes, at day 80 differentiation - ventricular cardiomyocytes.

   August 7th, 2019 at 5:53pm
Source Publication
Transcriptionally active HERV-H retrotransposons demarcate topologically associating domains in human pluripotent stem cells.
Zhang Y, Li T, et al., Nature genetics 2019

Properties  

Experiment Type 
in situ Hi-C
Follows SOP 
No
Biosample 
4DNBSALOG2AG
Digestion Enzyme 
MboI
Biosample Modifications 
None
Biosample Treatments 
None
Biosample Biosource 
H9 with targeted integration of GFP-tagged MYL2 - 4DNSRIIEMLZR

Experiment SetOpen In Search View

Initializing...